MarkAnthonySchumacherMD
Anesthesiology • San Francisco, CAPain Medicine
Associate Professor, Anesthesia & Perioperative Care, UCSF School of Medicine
Are you Dr. Schumacher?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 53 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Ucsf Medical Center 513 Parnassus Ave
Room S436 ( Box 0427)
San Francisco, CA 94143Phone+1 415-502-7022Fax+1 415-514-0185
Summary
- Dr. Mark Schumacher, MD is a board certified anesthesiologist in San Francisco, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center, Kaiser Permanente San Francisco Medical Center, and Zuckerberg San Francisco General Hospital and Trauma Center.
Education & Training
University of California (San Francisco)Residency, Anesthesiology, 1990 - 1993
University of California San Diego School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1991 - 2025- American Board of Anesthesiology Anesthesiology
Publications & Presentations
PubMed
- 52 citationsMultiple messenger RNA species give rise to the structural diversity in acetylcholinesteraseMark Schumacher, Yves Maulet, Shelley Camp, Palmer Taylor
The Journal of Biological Chemistry. 1988-12-15 - 290 citationsExpression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structuresSonja Ständer, Corinna Moormann, Mark Schumacher, Jörg Buddenkotte, Metin Artuc
Experimental Dermatology. 2004-03-01 - 88 citationsThe Involvement of Hypothalamic Sleep Pathways in General Anesthesia: Testing the Hypothesis Using the GABAA Receptor β3N265M Knock-In MouseAnna Y. Zecharia, Laura E. Nelson, Thomas C. Gent, Mark Schumacher, Rachel Jurd
The Journal of Neuroscience. 2009-02-18
Press Mentions
Feds Award $3 Million in Grants to Study Marijuana Ingredients as Alternatives to OpioidsOctober 1st, 2019
NIH to Investigate Minor Cannabinoids and Terpenes for Potential Pain-Relieving PropertiesSeptember 23rd, 2019
U.S. Government Announces $3 Million in Research Grants to Study Whether CBD Can Relieve PainSeptember 20th, 2019
Grant Support
- Capsaicin Receptor Subtypes In Pain TransductionNational Institute Of Neurological Disorders And Stroke1999–2011
